Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MORF | Common Stock | Options Exercise | $750K | +50K | +207.16% | $15.00 | 74.1K | Apr 25, 2023 | Direct | |
transaction | MORF | Common Stock | Sale | -$2.74M | -50K | -67.44% | $54.71 | 24.1K | Apr 25, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MORF | Stock Option (right to buy Common Stock) | Options Exercise | $0 | -50K | -39.29% | $0.00 | 77.3K | Apr 25, 2023 | Common Stock | 50K | $15.00 | Direct | F2 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated June 28, 2022. |
F2 | The option vested as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date. |